Guidance and Guidelines

Update: 2023-01-19

Description

Guidance and Guidelines

Comments

In Channel

Summary and Conclusions

2023-01-1902:34

Multidisciplinary Management

2023-01-1903:47

Cardiorenal Effects of Glucagon-Like Peptide-1 Receptor Agonists

2023-01-1910:59

Guidance and Guidelines

2023-01-1908:51

Glucagon-like Peptide Receptor Agonist

2023-01-1918:23

Standard of Care

2023-01-1910:25

Background

2023-01-1908:58

Introduction

2023-01-1900:57

00:00

Annenberg Center for Health Sciences